Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

Dow Jones Top Company Headlines at 11 AM ET: Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges | Charter, ... Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market ...

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are ...

People on GLP-1 medication seem to be adding more protein to their diets, further increasing demand for chicken and beef at a ...

Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...

The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

The company pointed to "recent market challenges" and "share price decline" as reasons for Lars Fruergaard Jørgensen's ...